On account of various pharmacokinetic profiles, oral formulations will not be interchangeable with extended launch on an mg-mg foundation because of distinctive pharmacokinetic profilesCan be presented as monotherapy or as adjunctive therapy with stimulants. The extended-launch is not interchangeable Along with the fast-launch product.Combining the